Medical Science Liaison

Medical Science Liaison (MSL), Oncology (Skin Cancers)

Territory: Central and Western United States

Role Overview

The MSL, Oncology (Skin Cancers) will join a fast-growing Field Medical Affairs team focused on commercializing the novel Signatera™ molecular residual disease (MRD) test. This role is dedicated to supporting oncologists and cancer researchers across solid tumors—with a primary emphasis on skin cancers—alongside complementary products and services within Natera’s oncology portfolio.

In 2019, the FDA designated Signatera as a Breakthrough Device, and Medicare proposed coverage for its use in patients with Stage II–III colorectal cancer as its first indication. We are seeking a smart, mission-oriented Medical Affairs professional who can communicate effectively to help transform the management of cancer worldwide. The MSL serves as a vital field-based scientific resource for clinicians, academic institutions, and professional organizations.

Primary Responsibilities

• Scientific Presentation: Deliver high-impact scientific and clinical presentations on Natera’s oncology products, specifically relevant to skin cancers.

• Information Support: Address the specific needs of customers by responding to requests for information about marketed and developing products across solid tumors.

• Internal Collaboration: Serve as a medical and scientific resource for Natera Sales and Marketing teams, including participation in scientific updates and training with an emphasis on skin cancer data.

• KOL Engagement: Identify, develop, and manage collaborative working relationships with Key Opinion Leaders (KOLs) in oncology, including dermatologists, surgeons, and medical oncology specialists.

• Research & Trials: Develop research collaborations with leading KOLs; assist with registry study enrollment and the management of Investigator-Initiated Trials (IITs) in solid tumors and skin cancer.

• Content Development: Review and develop educational materials and slide content for healthcare providers and patients—incorporating tumor-type–specific scientific context—subject to approval by Medical Affairs and Marketing.

• Events & Symposia: Assist in agenda planning and facilitation for Clinical Advisory Boards and Symposia involving cutaneous oncology experts.

• Compliance: Work regularly with Protected Health Information (PHI) in both paper and electronic forms, utilizing secure technologies to perform responsibilities.

Qualifications

• Advanced Degree: Health care professionals with relevant clinical sciences knowledge in oncology (e.g., Pharm.D, Ph.D., M.D., or DNP).

• Professional Experience: Prior MSL experience is highly preferred.

• Specialization: Prior involvement with cutaneous oncology or clinical laboratory tests (molecular diagnostics) is preferred.

Knowledge, Skills, and Abilities

• Communication: Independent thinker and persuasive communicator with an outgoing and confident demeanor.

• Relationship Building: Proven experience establishing strong, collaborative working relationships with internal stakeholders (Sales, Marketing, Regulatory, R&D) and external oncology customers.

• Presentation Skills: Outstanding oral presentation skills, particularly when conveying complex scientific concepts related to solid tumors.

• Autonomy: Ability to work independently and remotely while maintaining a strong teamwork ethic.

• Scientific Acumen: Strong knowledge of molecular biology and clinical oncology; familiarity with the cutaneous cancer treatment landscape is a significant plus.

 

The pay range is listed and actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. This may differ in other locations due to cost of labor considerations.Remote USA$150,000—$170,000 USD

OUR OPPORTUNITY

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable